3
Announcements
Trials
Browse
Landscape
Phase
Phase 4
1
Status
Terminated
1
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Conditions
Breast Neoplasms
50
Prostatic Neoplasms
44
Multiple Myeloma
22
Neoplasm Metastasis
17
Osteoporosis
14
Pain
11
Neoplasms
8
Carcinoma, Non-Small-Cell Lung
7
Neoplasms, Plasma Cell
5
Lung Neoplasms
5
Bone Diseases, Metabolic
5
Fractures, Bone
4
Bone Diseases
4
Lymphoma
3
Carcinoma, Renal Cell
3
Bone Neoplasms
3
Spinal Cord Compression
2
Ovarian Neoplasms
2
Osteosarcoma
2
Neuroblastoma
2
Kidney Neoplasms
2
Humoral Hypercalcemia Of Malignancy
2
Triple Negative Breast Neoplasms
1
Treatment of Bone Metastases
1
Small Cell Lung Carcinoma
1
Sarcoma, Ewing
1
Sarcoma
1
Renal Insufficiency
1
Recurrence
1
Pleural Effusion, Malignant
1
Interventions
Carboplatin
7
Paclitaxel
6
Talc
5
Docetaxel
5
Bevacizumab
4
Taxes
3
Gemcitabine
3
Cisplatin
3
Trastuzumab
2
High-Energy Shock Waves
2
Erlotinib Hydrochloride
2
Doxycycline
2
Cetuximab
2
Bortezomib
2
viscum album peptide
1
tipifarnib
1
saracatinib
1
romidepsin
1
endostar protein
1
Zoledronic Acid
1
Vinorelbine
1
Valacyclovir
1
Tyrosine Kinase Inhibitors
1
Thoracoscopy
1
Thoracoscopes
1
Thoracic Surgery, Video-Assisted
1
Thoracentesis
1
Surveys and Questionnaires
1
Sorafenib
1
Povidone-Iodine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Pleural Effusion, Malignant
×
Zoledronic Acid
×
Clear all
NCT00099541
2009-11-23
Non-small Cell Lung Cancer Registry
Novartis
Phase 4
Completed
300 enrolled